Coen Maas

Assistant Professor

Strategic program(s):

Contact

Plasmin-mediated proteolysis of von Willebrand factor in patients with acute and chronic liver disease Hinde El Otmani, Marilena Stamouli, Jelle Adelmeijer, William Bernal, Coen Maas, Vishal C. Patel, Ton Lisman
Research and practice in thrombosis and haemostasis, 2025, vol. 9

In vivo activation of coagulation during human liver transplantation is associated with activation of the intrinsic pathway Fynn L. Elvers, Jelle Adelmeijer, Sarah Bos, Coen Maas, William Bernal, Ton Lisman
Research and practice in thrombosis and haemostasis, 2025, vol. 9

Factor XII contact activation can be prevented by targeting 2 unique patches in its epidermal growth factor-like 1 domain with a nanobody Rowan Frunt, Hinde El Otmani, Simone Smits, Chantal C Clark, Coen Maas
Journal of thrombosis and haemostasis : JTH, 2024, vol. 22, p.2562-2575

Taking aim at titanium Rowan Frunt, Simone Smits, Coen Maas
Journal of Thrombosis and Haemostasis, 2023, vol. 21, p.1109-1111

Insights in the Prothrombotic Changes after Implantation of a Left Ventricular Assist Device in Patients with End-Stage Heart Failure Omayra C.D. Liesdek, Rolf T. Urbanus, Steven De Maat, Linda M. De Heer, Faiz Z. Ramjankhan, Silvie A.E. Sebastian, Albert Huisman, Nicolaas De Jonge, Aryan Vink, Kathelijn Fischer, Coen Maas, Willem J.L. Suyker, Roger E.G. Schutgens
ASAIO journal, 2023, vol. 69, p.438-444

VWF-targeted thrombolysis to overcome rh-tPA resistance in experimental murine ischemic stroke models Marc V.A. van Moorsel, Steven de Maat, Kristof Vercruysse, Esther M. van Leeuwen, Charlène Jacqmarcq, Thomas Bonnard, Denis Vivien, H. Bart van der Worp, Rick M. Dijkhuizen, Coen Maas
Blood, 2022, vol. 140, p.2844-2848

Consultancy tbv ontwikkeling eiwitmedicijnen - Expertise in diagnostiek en behandeling van hart en vaatziekten - Coenami BV